Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report

(E-pub Ahead of Print)

Author(s): Gianfranco Calogiuri*, Eustachio Nettis, Alessandro Mandurino-Mirizzi, Elisabetta Di Leo, Luigi Macchia, Caterina Foti, Angelo Vacca, Nichlas G. Kounis.

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents)

Become EABM
Become Reviewer


The anti-IgE Omalizumab may be helpful to treat clopidogrel hypersensitivity without stopping thienopyridine administration in patients needing to assume double antiplatelet therapy continuosly after coronary stent placement.

Keywords: Omalizumab, Clopidogrel, Thienopyridines, Prasugrel, Ticafrelor

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1871523018666190522105055

Article Metrics

PDF: 7